Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Healthcare Realty Trust (HR)
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-11-04
$19.07-1.90%
Close 2026-11-05 · 1-day change
NYSEReal EstateReit - Healthcare FacilitiesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.09 → 0.08 EPS · FY ending Dec 31, 2027 · 3 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 3; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for HR yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain strategic capital allocation including $700M debt issuance | Debt issuance supports capital allocation and financial flexibility. | Improving | no further capital allocation actions or increased debt capacity by end 2026 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
HR is a real estate operating story, with recent financial performance strong but earnings quality still loss-making. The long-term thesis is intact, though management has been described as volatile and the risk label has moved from low to moderate.
Valuation is tagged as justified, with expectations broadly aligned with the evidence and no major fragility signals. The model shows a small negative expectations gap and medium confidence, so the evidence does not point to a large gap between current expectations and the business setup.
Near term, third-quarter same-store cash NOI growth was 5.1%, and management raised full-year guidance to 5.00% to 5.25%; revenue also rose from the second to the third quarter of 2026. However, revenue was lower year over year, and acquisition and disposition execution is mixed; a guidance reversal would further test management credibility.
The multi-year view hinges on sustaining same-store cash NOI growth while managing acquisitions, dispositions, and redevelopment projects. Near-term, Fed rate cuts could support real estate, while weakness among sector bellwethers could remove that tailwind.
Over the next 1 to 3 years, HR’s thesis rests on continued operating delivery and steady guidance, against a backdrop of loss-making earnings quality and moderate risk. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 1 of 4 supplied quarters. Management reported: “Completed strategic market exits of the El Paso, TX; Des Moines, IA; Fort Wayne, IN; Cincinnati, OH; Salt Lake City, UT; Las Vegas, NV; and Kokomo, IN MSAs with the sale of a 25-property portfolio for $348.9 million to a single private purchaser, reducing exposure to non-priority markets and further refining the Company's core operating portfolio • Phoenix, AZ.” “SECTION 1 Strategic Plan Update | 15 Rapid Execution of Healthcare Realty 2.0 Strategic Plan Corporate Governance Organizational Platform Restructuring Portfolio Optimization Reprioritized Capital Allocation Balance Sheet Management Achievements to Date Significant Progress on Strategic Plan with Clear Path to Completion Progress Achieved mid-5x Net Debt / Adj.”
Increase cash from operations to at least $53 million | The company aims to improve cash flow from operations, which was $52.9 million in Q1 2026. | Improving | cash from operations falls below $40 million next year | Cash from operations: $0 FY2026-Q3; GAAP. Published target: >=52.9 million USD. The stored target says 2026-Q1; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Oct 29, 20260 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Sustain dividend payout at $0.24 per share | It raised its dividend to $0.24 per share and secured $700 million in notes. | Intact | dividend per share falls below $0.20 next year | Dividend per share: $0.24 per share FY2026-Q3; GAAP. Published target: >=0.24 USD per share. The stored target says 2026-Q1; this source reports FY2026-Q3. Fiscal/calendar alignment needs review. Oct 29, 20260.24 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in a supplied disclosure. Management reported: “SECTION 1 Strategic Plan Update | 15 Rapid Execution of Healthcare Realty 2.0 Strategic Plan Corporate Governance Organizational Platform Restructuring Portfolio Optimization Reprioritized Capital Allocation Balance Sheet Management Achievements to Date Significant Progress on Strategic Plan with Clear Path to Completion Progress Achieved mid-5x Net Debt / Adj.” “SECTION 1 Strategic Plan Update | 15 Rapid Execution of Healthcare Realty 2.0 Strategic Plan Corporate Governance Organizational Platform Restructuring Portfolio Optimization Reprioritized Capital Allocation Balance Sheet Management Achievements to Date Significant Progress on Strategic Plan with Clear Path to Completion Progress Achieved mid-5x Net Debt / Adj.” Delivery assessment Nov 4, 2026 |
EPS improves toward break-even (>= $0.00) | It raised its dividend to $0.24 per share and secured $700 million in notes. | Improving | EPS falls below -$0.05 in 2026 | Diluted EPS: $-0.05 per share FY2026-Q3; GAAP. Published target: >=0.00 USD per share. Target period ends 2026-12-31; this observation covers 2026-Q3. Oct 29, 2026-0.05 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.02 → $0.08 · observed estimates
$1.14B → $1.14B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.02 | $1,142,242,420 | 2 / 7 |
| 2026-07-25 | $0.05 | $1,135,978,638 | 2 / 5 |
| 2026-07-26 | $0.02 | $1,160,841,200 | 2 / 5 |
| 2026-07-27 | $0.05 | $1,135,829,900 | 2 / 5 |
| 2026-07-28 | $0.02 | $1,160,841,200 | 2 / 5 |
| 2026-07-29 | $0.02 | $1,160,841,200 | 2 / 5 |
| 2026-07-30 | $0.05 | $1,135,829,900 | 3 / 4 |
| 2026-07-31 | $0.02 | $1,160,841,200 | 2 / 5 |
| 2026-08-01 | $0.05 | $1,135,829,900 | 3 / 3 |
| 2026-08-02 | $0.05 | $1,138,250,833 | 3 / 3 |
| 2026-08-03 | $0.02 | $1,167,391,500 | 2 / 4 |
| 2026-08-04 | $0.02 | $1,167,391,500 | 2 / 4 |
| 2026-08-05 | $0.02 | $1,167,391,500 | 2 / 4 |
| 2026-08-06 | $0.02 | $1,167,391,500 | 2 / 4 |
| 2026-08-07 | $0.05 | $1,138,250,833 | 3 / 3 |
| 2026-08-08 | $0.02 | $1,175,188,660 | 2 / 3 |
| 2026-08-09 | $0.02 | $1,175,188,660 | 2 / 3 |
| 2026-08-10 | $0.02 | $1,175,188,660 | 2 / 3 |
| 2026-08-12 | $0.02 | $1,172,516,500 | 2 / 4 |
| 2026-08-13 | $0.05 | $1,138,250,833 | 3 / 3 |
| 2026-08-14 | $0.05 | $1,138,250,833 | 3 / 3 |
| 2026-08-15 | $0.05 | $1,138,250,833 | 3 / 3 |
| 2026-08-16 | $0.05 | $1,138,250,833 | 3 / 3 |
| 2026-08-17 | $0.05 | $1,138,250,833 | 3 / 3 |
| 2026-08-18 | $0.05 | $1,138,250,833 | 3 / 3 |
| 2026-08-19 | $0.05 | $1,138,250,833 | 3 / 3 |
| 2026-08-20 | $0.06 | $1,141,284,167 | 3 / 3 |
| 2026-08-21 | $0.06 | $1,141,284,167 | 3 / 3 |
| 2026-08-22 | $0.06 | $1,141,284,167 | 3 / 3 |
| 2026-08-23 | $0.06 | $1,142,395,278 | 2 / 3 |
| 2026-08-24 | $0.06 | $1,142,395,278 | 2 / 3 |
| 2026-08-25 | $0.07 | $1,142,395,278 | 3 / 3 |
| 2026-08-26 | $0.07 | $1,142,395,278 | 3 / 3 |
| 2026-08-27 | $0.07 | $1,142,395,278 | 3 / 3 |
| 2026-08-28 | $0.07 | $1,142,395,278 | 3 / 3 |
| 2026-08-29 | $0.07 | $1,142,395,278 | 3 / 3 |
| 2026-08-30 | $0.07 | $1,142,395,278 | 3 / 3 |
| 2026-08-31 | $0.07 | $1,142,395,278 | 3 / 3 |
| 2026-09-01 | $0.07 | $1,142,395,278 | 3 / 3 |
| 2026-09-02 | $0.07 | $1,142,395,278 | 3 / 3 |
| 2026-09-03 | $0.09 | $1,136,029,167 | 3 / 3 |
| 2026-09-04 | $0.09 | $1,136,631,239 | 3 / 3 |
| 2026-09-05 | $0.09 | $1,136,631,239 | 3 / 3 |
| 2026-09-06 | $0.09 | $1,136,631,239 | 3 / 3 |
| 2026-09-07 | $0.09 | $1,136,631,239 | 3 / 3 |
| 2026-09-08 | $0.09 | $1,136,631,239 | 3 / 3 |
| 2026-09-09 | $0.09 | $1,136,631,239 | 3 / 3 |
| 2026-09-10 | $0.09 | $1,136,631,239 | 3 / 3 |
| 2026-09-11 | $0.09 | $1,136,631,239 | 3 / 3 |
| 2026-09-12 | $0.09 | $1,136,631,239 | 3 / 3 |
| 2026-09-13 | $0.09 | $1,136,631,239 | 3 / 3 |
| 2026-09-14 | $0.09 | $1,136,631,239 | 3 / 3 |
| 2026-09-15 | $0.09 | $1,136,631,239 | 3 / 3 |
| 2026-09-16 | $0.09 | $1,136,631,239 | 3 / 3 |
| 2026-09-17 | $0.09 | $1,136,631,239 | 3 / 3 |
| 2026-09-18 | $0.09 | $1,136,631,239 | 3 / 3 |
| 2026-09-19 | $0.09 | $1,136,631,239 | 3 / 3 |
| 2026-09-20 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-09-21 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-09-22 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-09-23 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-09-24 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-09-25 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-09-26 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-09-27 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-09-28 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-09-29 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-09-30 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-10-01 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-10-02 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-10-03 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-10-04 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-10-05 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-10-06 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-10-07 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-10-08 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-10-09 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-10-10 | $0.09 | $1,136,661,333 | 3 / 3 |
| 2026-10-11 | $0.08 | $1,135,831,889 | 3 / 4 |
| 2026-10-12 | $0.08 | $1,135,831,889 | 3 / 4 |
| 2026-10-13 | $0.08 | $1,135,831,889 | 3 / 4 |
| 2026-10-14 | $0.08 | $1,135,831,889 | 3 / 4 |
| 2026-10-15 | $0.08 | $1,135,831,889 | 3 / 4 |
| 2026-10-16 | $0.08 | $1,135,831,889 | 3 / 4 |
| 2026-10-17 | $0.08 | $1,135,831,889 | 3 / 4 |
| 2026-10-18 | $0.08 | $1,135,831,889 | 3 / 4 |
| 2026-10-19 | $0.08 | $1,135,831,889 | 3 / 4 |
| 2026-10-20 | $0.08 | $1,136,276,333 | 3 / 4 |
| 2026-10-21 | $0.08 | $1,136,276,333 | 3 / 4 |
| 2026-10-22 | $0.07 | $1,134,741,071 | 3 / 4 |
| 2026-10-23 | $0.07 | $1,134,741,071 | 3 / 4 |
| 2026-10-24 | $0.07 | $1,134,741,071 | 3 / 4 |
| 2026-10-25 | $0.07 | $1,134,741,071 | 3 / 4 |
| 2026-10-26 | $0.07 | $1,134,741,071 | 3 / 4 |
| 2026-10-27 | $0.07 | $1,134,741,071 | 3 / 4 |
| 2026-10-28 | $0.07 | $1,134,741,071 | 3 / 3 |
| 2026-10-29 | $0.07 | $1,134,752,301 | 3 / 3 |
| 2026-10-30 | $0.07 | $1,134,722,212 | 3 / 3 |
| 2026-10-31 | $0.07 | $1,134,722,212 | 3 / 3 |
| 2026-11-01 | $0.07 | $1,134,722,212 | 3 / 3 |
| 2026-11-02 | $0.07 | $1,136,882,545 | 3 / 3 |
| 2026-11-03 | $0.08 | $1,135,511,101 | 3 / 3 |
| 2026-11-04 | $0.08 | $1,135,511,101 | 3 / 3 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 5 Buy / Strong Buy · 8 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 3 recorded
0 raises · 0 cuts · 0 unchanged · 1 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.